Cognitive profiles and predictors of cancer-related cognitive impairment in breast cancer survivors: integrating self-reported, neuropsychological, and process-based measures
CRCI assessment should include self-reported and neuropsychological measures, and MoCA should not replace comprehensive neuropsychological assessment, while BPA may provide complementary meaningful information to characterize CRCI profiles.
Abstract
Abstract Objective Characterizing cancer-related cognitive impairment (CRCI) remains challenging due to limitations in the sensitivity of neuropsychological tests and diagnostic criteria. This study aimed to (a) classify breast cancer survivors in CRCI groups using self-reported and neuropsychological categories; (b) explore whether CRCI is related to specific cognitive domains; (c) analyze if comorbid symptoms predict CRCI group membership; (d) study the correspondence between Montreal Cognitive Assessment (MoCA) and neuropsychological CRCI; and (e) explore cognitive profiles of CRCI groups considering Boston Process Approach (BPA) indices. Method This cross-sectional study included 82 breast cancer survivors undergoing treatment and presenting mild depressive symptoms. Self-reported CRCI was assessed using the PROMIS-CF 8a, neuropsychological CRCI was defined following recommended criteria. Participants were classified into four independent CRCI groups: (a) non-CRCI; (b) subjective CRCI; (c) objective CRCI; (d) combined CRCI. Logistic regression models examined predictors, χ2 tests assessed MoCA correspondence, and group differences in BPA indices were studied through ANOVA. Results Participants’ mean age was 47.76 years, 71.95% exhibited self-reported CRCI and 48.78% neuropsychological CRCI. Anxiety predicted subjective and combined CRCI, while lower self-efficacy predicted combined CRCI. MoCA showed limited sensitivity and specificity for neuropsychological CRCI. The combined CRCI group exhibited poorer quality of life and lower performance on processing speed and verbal fluency tasks. Conclusions CRCI assessment should include self-reported and neuropsychological measures. MoCA should not replace comprehensive neuropsychological assessment, while BPA may provide complementary meaningful information to characterize CRCI profiles. CRCI interventions should target executive functioning, anxiety, and self-efficacy. Longitudinal studies with control groups are required.
Cancer-related cognitive impairment (CRCI) is a multifaceted symptom associated with various comorbid conditions, complicating management. This study aims to evaluate cumulative symptom burden and its impact on both subjective and objective CRCI in breast cancer survivors. Enrollment data were analyzed from a randomize...
Xiao-Tong Li, K. Lampson, Kevin T. Liou et al.· Breast Cancer Research and T...· 0 citations
CRCI may occur during certain types of chemotherapy but appears to ameliorate over time, and Ongoing endocrine therapy may have longer-lasting impact on cognitive function.
Qiqi Lei, M. Schmidt, P. Zimmer et al.· International Journal of Can...· 0 citations
The findings revealed an association between perceived cognitive impairment (PCI) and quality of life among non-CNS cancer patients before treatment and the need for cognitive and quality of life screening before treatment and implementation of early interventions to prevent deterioration and to improve health outcomes...
T. Motsamai, A. Lentoor· Discover Public Health· 0 citations
Objective: To compare associations between neurocognitive testing and two different self-report paradigms: 1) recall-based (PROMIS Cognitive Function); and 2) real-time, task-specific (NASA-Task Load Index [NASA-TLX]) among 56 patients with breast cancer. Method: This is a secondary analysis from a phase II, single-arm...
Z. Nakamura, Brent J. Small, T. Ahles et al.· Journal of the International...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.